Rudolf Steiner on cancer and mistletoe-
Cancer can grow where the vital force withdraws from the physical and leaves a “void”, “… mistletoe counteracts this "void” and draws the etheric forces again to the area which they do not want to enter…
Mistletoe provides, beyond question, a means which - when given in potencies - should enable us to dispense with the surgical removal of tumors. The point is only to find out how to treat the mistletoe fruit in combining it with other forces of the mistletoe plant, in order to arrive at a remedy.”
-Rudolf Steiner, Spiritual Science and Medicine, Lecture XIII, 4/20/1920
Modern science has reaffirmed the therapeutic importance of mistletoe, through identification of the viscotoxins (literally, "mistletoe toxins"), lectins, and alkaloids thought to be responsible for its anticancer and immune modifying activities. Presently 60% of all cancer patients in Germany and Switzerland are prescribed mistletoe at some point in their treatment.
Learn more about groundbreaking research...
Licensed medical prescribers seeking more information and training in the use of mistletoe are invited to register for the Best Practices Mistletoe Course, happening in Baltimore, Maryland, June 21-23, 2019.
The mistletoe family contains more than 1000 species, however, anticancer drugs are derived solely from viscum album (common or European mistletoe). Viscum album occurs across a small number of host-trees. The host trees are: apple (mali), pine (pini), fir (abietis), oak (quercus), hawthorn (crataegus), ash (fraxini), elm (ulmi), and poplar (populi).
There are currently four main European mistletoe producers:
Iscador by Iscador AG www.iscador.com/en (from 5 host trees)
Helixor Viscum by Helixor (from 3 host trees)
Iscucin by WALA www.wala.de (from 8 host trees)
Abnoba Viscum by Abnoba www.abnoba.de (from 5 host trees)
More information and exemplary literature can be found here on the cancer disease and mistletoe treatment page of the Medical Section at the Goetheanum.
Information can also be found on the CDC website at: http://www.cancer.gov/about-cancer/treatment/cam/hp/mistletoe-pdq
Please see the article: MISTLETOE THERAPY AND CANCER-AN OVERVIEW 2014 by Dr. med. Gunver S. Kienle, IFAEMM Freiburg.
An extensive number of articles and studies can also be found in the AnthroMed Library section on Mistletoe and Immunology Research